SEC Form 4 · accession 0001104659-17-041339
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Trachtenberg
Officer — GC, CCO & Secretary
Period of report
Jun 23, 2017
Accepted (ET)
Jun 23, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Jun 23, 2017 | S | 7,720 | $1.33 | D | 201,564 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 25,000 restricted stock units, which vested on June 22, 2017. 6,250 of such restricted stock units were previously granted on June 22, 2015 and 18,750 of such restricted stock units were previously granted on February 12, 2016.